A promising TB vaccine can be protected from heat damage with a technique developed at the University of Bath.
Scientists working on a new tuberculosis (TB) vaccine have achieved a major step forward by showing that a promising TB antigen and a novel vaccine adjuvant can be protected from heat damage with a technique developed at the University of Bath.
Their method prevents these crucial vaccine components from spoiling outside of a fridge – meaning a thermally stable vaccine that can be reliably delivered to remote areas around the world is more likely.
There is an urgent need not only for a new TB vaccine, but also for methods to keep vaccines stable outside of the refrigeration ‘cold chain’ – as up to 50% of vaccine doses are discarded before use due to exposure to suboptimal temperatures. Thermostable vaccines have therefore been named a priority research area in the World Health Organisation’s Global Vaccine Action Plan 2011-2020.
Ensilication, a method developed at the University of Bath, “shrink-wraps” vaccine proteins in position using layers of silica that build up into a cage around the molecules – so they don’t unravel when exposed to temperatures that would usually break them down. The proteins are held in place until ready to be removed from the silica cage and delivered.
The research team from the Departments of Biology & Biochemistry and Chemistry first demonstrated that the TB antigen ag85b and a vaccine fused with the adjuvant protein Sbi are sensitive to breaking down outside of refrigerated temperatures. They then showed that these vaccine components were protected from heat damage when ensilicated and kept on a shelf at room temperature for long periods of time without loss of structure and function.
This is first time that ensilication has been used to improve the thermal stability of proteins in a vaccine setting, after proof-of-principle work using model proteins.
The results are a big step forward not only in developing a thermally-stable TB vaccines, but in showing that ensilication could be used for many different kinds of vaccines.
The study is published in Scientific Reports
Lead author Professor Jean van den Elsen, said: “A new TB vaccine is really urgently needed to supplement or replace the existing BCG vaccine and reduce the number of TB cases and deaths – particularly as drug-resistant TB infections remain high.”
First author Ayla Wahid, added: “To make the vaccine as effective as possible it needs to be thermally-stable, or in other words not spoil outside of a fridge, which is why we’re really encouraged by these results. Cold-chain storage leads to a lot of wastage and expense which could be avoided by ensilication.”
Dr Asel Sartbaeva, who invented ensilication, added: “Our results reveal the potential of ensilication in storing and transporting life-saving vaccines at ambient temperatures globally – in particular to remote areas of developing countries where disease rates are often highest.
“With up to 50% of vaccines being thrown away, and refrigeration raising vaccine costs by up to 80%, this is a major global health challenge that we need to overcome. By demonstrating for the first time that ensilication works to protect vaccine-relevant proteins from breaking down outside a fridge we’re a big step closer to achieving this goal.”
The Latest on: TB vaccine
via Google News
The Latest on: TB vaccine
- Wild bison set to be tested for TB using new blood teston February 23, 2020 at 10:09 pm
While a successful Canadian bovine TB control programme has been in place since 1924 ... Volker Gerdts, director of the University of Saskatchewan's Vaccine and Infectious Disease ...
- Old TB vaccine works better when injected into vein —Researcherson February 23, 2020 at 8:12 pm
Tessy IgomuThe World Health Organisation has said that achieving 95 per cent reduction in deaths from tuberculosis on the one hand, and another 90 per cent reduction in tuberculosis incidence ...
- New TB vaccine could be a therapy for bladder canceron February 23, 2020 at 2:58 am
In a new study, researchers have genetically modified the tuberculosis vaccine BCG in a way that it stimulates the immune system more specifically. The new vaccine VPM1002 offers much greater ...
- Vaccination, awareness keeping JE in check, says health depton February 22, 2020 at 3:23 pm
Madurai: Proper vaccination measures and increased awareness about Japanese Encephalitis (JE ... When it comes to encephalitis, bacterial meningitis and TB meningitis are more common and these are ...
- TB Vaccines Market Interpretation and Benefit Growth to 2029 | Merck & Co.,Inc and Sanofi Pasteuron February 18, 2020 at 2:26 am
TB Vaccines Market Moving Towards 2020 With New Procedures, Provides Exhaustive PEST Analysis by 2029 | North America, Europe, APAC, MEA and South and Central America.” An executive summary created ...
- Vaccination will prevent millions of TB cases yearly ― Donon February 18, 2020 at 12:21 am
will expand the age-long fight against the disease. Choukwa told News Agency of Nigeria (NAN) on Monday, in Abuja that a TB vaccine is being sponsored by the Bill & Melinda Gates Medical Research ...
- Adjuvants: vaccines’ hidden helperson February 17, 2020 at 1:42 am
Shingrix, launched in 2017, was predicted to exceed £1 billion in sales in 2019. For TB we are not much further on than we were in the 1880s The AS01 adjuvant is also included in a GSK candidate ...
- Kemri researchers develop world's first adult TB vaccineon February 14, 2020 at 10:43 am
Kenyan researchers from the Kenya Medical Research Institute were involved in its trials. Results presented in Nairobi yesterday show the experimental vaccine successfully prevents TB in half of all ...
- BCG Tuberculosis (TB) Vaccine Market 2020 In Deep Analysis, Expert Reviews and Healthcare Outlook 2026; Merck & Co. Inc.(nys:MRK)on February 12, 2020 at 7:03 am
The BCG Tuberculosis (TB) Vaccine Market recently Published Global Market research study with more than 100 industry informative desk and Figures spread through Pages and easy to understand detailed ...
- Recent progress in TB diagnostics and prevention approaches offers hope for futureon February 11, 2020 at 7:19 pm
Advances in TB vaccine development in 2019 included exciting preclinical and clinical results from several studies, the Perspective authors write. A study in macaques, in which the Bacille ...
via Bing News